Abbott surges on launching COVID-19 home test kit in India

13 Jul 2021 Evaluate

Abbott India is currently trading at Rs. 17388.20, up by 99.05 points or 0.57% from its previous closing of Rs. 17289.15 on the BSE.

The scrip opened at Rs. 17337.85 and has touched a high and low of Rs. 17388.20 and Rs. 17225.05 respectively.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 17500.00 on 12-Jul-2021 and a 52 week low of Rs. 13970.10 on 02-Feb-2021.

Last one week high and low of the scrip stood at Rs. 17500.00 and Rs. 16780.00 respectively. The current market cap of the company is Rs. 36657.38 crore.

The promoters holding in the company stood at 74.99%, while Institutions and Non-Institutions held 6.54% and 18.47% respectively.

Abbott has launched COVID-19 home test kit in India for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms at a price of Rs 325 for a single test kit pack.

The company will deliver millions of Panbio COVID-19 rapid antigen tests, available for self-use, to ease the burden on healthcare systems in urban and rural India.

Abbott India is healthcare company that discovers, develops, manufactures and markets innovative products and services.

Abbott India Share Price

28805.00 295.80 (1.04%)
31-Dec-2025 11:33 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.45
Dr. Reddys Lab 1266.30
Cipla 1499.20
Zydus Lifesciences 911.05
Lupin 2093.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×